MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
Hepatocellular carcinoma (HCC) is the fifth most common neoplasm and the third leading cause of cancer-related deaths worldwide. Cirrhosis, most often due to viral hepatitis, is the predominant risk factors for HCC and geographical differences in both risk factors and incidence are largely due to ep...
Saved in:
| Main Authors: | Alessandro Granito, Luigi Bolondi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2009-11-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Online Access: | http://www.mjhid.org/index.php/mjhid/article/view/146 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Systemic treatments for hepatocellular carcinoma: challenges and future perspectives
by: Francesco Tovoli, et al.
Published: (2018-01-01) -
Nanoparticles and the treatment of hepatocellular carcinoma
by: Zhang Ziyu, et al.
Published: (2024-12-01) -
Etiologic, epidemic, medical and economic aspects of hepatocellular carcinoma
by: N. A. Vlasova, et al.
Published: (2025-02-01) -
Role of Immunotherapy in the Treatment of Hepatocellular Carcinoma
by: Irina Y. Dobrosotskaya, et al.
Published: (2025-04-01) -
New Insights into the Diagnosis and Treatment of Hepatocellular Carcinoma
by: Chengbo Li, et al.
Published: (2025-05-01)